+86 189 1304 2753 product@eynoslifescience.com

The company was founded on 23 September 2024 and is based in the Jiangbei New Area of Nanjing, China. It sells both column-free negative-selection kits and column-based nanobeads, covering human and mouse T, B, NK, monocyte, neutrophil, dendritic and progenitor populations.

Around the separation products, the catalogue covers activation beads, Treg/Th1/Th2 differentiation kits, media and cytokines, envelope-engineered lentivirus for hard-to-transduce hematopoietic cells, retroviral vectors for mouse primary cells, and off-the-shelf CAR vectors. A technical service chain runs from tissue dissociation through sorting, differentiation, gene modification and virus packaging to CAR-T design and manufacturing.

All products are for research use only. Every catalogue number ships with a numbered manual and a lot-level COA, and validation data are reported together with the sample and the caveats.

The full report is published in Chinese: 中文原文. This page is an English summary prepared by Eynos.

Questions about this report?

Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.